![Shelley A. Hartman](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Shelley A. Hartman
Chief Executive Officer at Aegle Therapeutics Corp.
Network origin in Shelley A. Hartman first degree
Entity | Entity type | Industry | |
---|---|---|---|
GMP Cos., Inc.
![]() GMP Cos., Inc. Pharmaceuticals: MajorHealth Technology GMP Cos., Inc. develops pharmaceuticals, diagnostic products, and medical devices. The firm is also working on treatments for diabetes, glaucoma, and spinal cord injuries. The company was founded in 1999 and is headquartered in Fort Lauderdale, FL
14
| Extinct | Pharmaceuticals: Major | 14 |
Aegle Therapeutics Corp.
![]() Aegle Therapeutics Corp. BiotechnologyHealth Technology Aegle Therapeutics Corp. is a biotechnology company, which isolates extracellular vesicles including exosomes (“EVs”) secreted by allogeneic bone marrow derived mesenchymal stem cells to treat dystrophic epidermolysis bullosa (“DEB”), a rare pediatric connective tissue disorder. Its EV therapy has the potential to demonstrate a safer, lower cost means of harnessing the regenerative healing power of stem cells without using the cells. The company was founded by Evangelos V. Badiavas, and Robert F. Williamson III in 2013 and is headquartered in Miami, FL.
7
| Holding Company | Biotechnology | 7 |
Seraxis, Inc.
![]() Seraxis, Inc. Pharmaceuticals: MajorHealth Technology Part of Seraxis Pte Ltd., Seraxis, Inc. is a biotechnology company that specializes in developing a proprietary human stem cell line, sr1423, and manufacturing process to generate pancreatic islets that mimic native islets in purity and potency. The company is based in Germantown, MD. The company has also developed the seragraft device and other tools to enable survival and function of the islet replacement therapy in immunocompetent hosts. Seraxis aims to be the first to provide diabetics a clinical solution for glucose control and complete autonomy from insulin injections. The company was founded in 2013 by William L. Rust, who has been the CEO since 2013.
6
| Subsidiary | Pharmaceuticals: Major | 6 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Shelley A. Hartman via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
JOHNSON & JOHNSON | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
Tiger Management LLC
![]() Tiger Management LLC Investment ManagersFinance Tiger Management LLC is an independent hedge fund manager founded by Julian Robertson in 1980. Headquartered in New York City, the firm manages Mr. Robertson's personal assets. | Investment Managers | Corporate Officer/Principal Sales & Marketing | |
LA JOLLA PHARMACEUTICAL COMPANY | Pharmaceuticals: Major | Director/Board Member | |
Frazier Management LLC
![]() Frazier Management LLC Investment ManagersFinance Frazier Management LLC (Frazier Healthcare Partners) is a venture capital subsidiary of Frazier & Co Inc. founded in 1991. The firm is headquartered in Seattle, Washington. | Investment Managers | Private Equity Investor | |
Ernst & Young LLP
![]() Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
LifeSync Corp.
![]() LifeSync Corp. Medical SpecialtiesHealth Technology LifeSync Corp. engages in the development, marketing, and sale clean disposable electrocardiogram technologies. Its products are lifesync wireless ECG system, and disposable leadwear a wireless electrocardiogram data communication system appropriate for use in hospital and outpatient. The company was founded in 2000 and is headquartered in Coral Springs, FL. | Medical Specialties | Director/Board Member Corporate Officer/Principal Director of Finance/CFO Sales & Marketing | |
Seraxis Holdings, Inc.
![]() Seraxis Holdings, Inc. Financial ConglomeratesFinance Seraxis Holdings, Inc. functions as an investment holding private company. The company is based in Germantown, MD. The CEO of the company is William L Rust. | Financial Conglomerates | Director/Board Member Director/Board Member Director/Board Member | |
ALUS Liquidation Corp.
![]() ALUS Liquidation Corp. Medical SpecialtiesHealth Technology ALUS Liquidation Corp. develops, manufactures, and sells medical products. The company is based in Irvine, CA. | Medical Specialties | Director/Board Member Chairman | |
Stanford University | College/University | Masters Business Admin Corporate Officer/Principal | |
TESARO INC | Pharmaceuticals: Major | Founder Corporate Officer/Principal | |
Seraxis Pte Ltd.
![]() Seraxis Pte Ltd. BiotechnologyHealth Technology Seraxis Pte Ltd. provides biotechnology services. It offers a cure for insulin-dependent diabetes by replacing the lost insulin producing pancreatic cells with lab-grown cells, packaged within a device to protect the cells from immune rejection. The company was founded by William L. Rust in March 2013 and is headquartered in Singapore. | Biotechnology | Director/Board Member Founder | |
University of Georgia | College/University | Undergraduate Degree Undergraduate Degree | |
Tellus Bioventures LLC
![]() Tellus Bioventures LLC Investment ManagersFinance Tellus BioVentures LLC (Tellus BioVentures) is a venture capital firm founded in 2019 by Leon O. Moulder. The firm is headquartered in Miromar Lakes, Florida. | Investment Managers | Chief Executive Officer Private Equity Investor | |
Praeventix, Inc.
![]() Praeventix, Inc. BiotechnologyHealth Technology Praeventix, Inc. is a biotechnology company founded by Dr. Douglas Pippin based on discoveries researched by Dr. Pippin and at Temple University. The company is based in Exton, PA, and was founded by Douglas Pippin. The company is initially focused on the development of pre-clinical candidate pra-523, a potential first-in-class neuromodulatory therapy for pruritus and other potential indications, including IBD. Praeventix is pursuing novel serotonergic therapeutics for inflammatory bowel disease (IBD) and cocaine use disorder (CUD). Douglas Pippin has been the CEO since incorporation. | Biotechnology | Director/Board Member Chief Operating Officer | |
Morgan Stanley & Co. LLC
![]() Morgan Stanley & Co. LLC Investment Banks/BrokersFinance Morgan Stanley & Co. LLC is a registered broker-dealer subsidiary of Morgan Stanley Domestic Holdings, Inc., ultimately owned by Morgan Stanley (NYSE: MS) in the US. Headquartered in New York City, the firm was founded in 1987 and provides debt and equity services including underwriting, M&A advice, securities dealing and brokerage and trade execution. Their client base ranges from large global institutional investors to hedge funds at the cutting edge of innovation in the industry. | Investment Banks/Brokers | Corporate Officer/Principal Analyst-Equity | |
University of Michigan | College/University | Undergraduate Degree | |
Entasis Therapeutics, Inc.
![]() Entasis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Entasis Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovey, development, and commercialization of novel antibacterial prodcuts to treat serious infections caused by multi-drug resistant Gram-negative bacteria. Its pipeline includes ETX2514SUL, targeting Acinetobacter baumannii infections; ETX0282CPDP, targeting Enterobacteriaceae infections; a Non-Beta-lactam PBP inhibitor, targeting Gram-negative infections; and zoliflodacin, targeting Neisseria gonorrhoeae. The company was founded by Manoussos Perros in May 2015 and is headquartered in Waltham, MA. | Pharmaceuticals: Major | Director/Board Member | |
APTINYX | Pharmaceuticals: Major | Director/Board Member | |
Acerta Pharma BV
![]() Acerta Pharma BV Pharmaceuticals: GenericHealth Technology Acerta Pharma BV develops drugs for oncology and autoimmune diseases. It operates as a biotech company that combines technology platforms in drug discovery and development such as the covalent technology platform and the multiparametric phosphoflow cytometry platform. The company was founded by Allard Kaptein in 2012 and is headquartered in Oss, Netherlands. | Pharmaceuticals: Generic | Director/Board Member | |
Bass Enterprises
![]() Bass Enterprises Investment ManagersFinance Bass Enterprises is an independent hedge fund manager headquartered in Fort Worth, Texas. It was founded by Sid R. Bass. The firm manages assets of high net worth individuals. | Investment Managers | Analyst-Equity | |
Mavupharma, Inc.
![]() Mavupharma, Inc. Pharmaceuticals: MajorHealth Technology Mavupharma, Inc. engages development of non-nucleotide, conditional modulators of the STING pathway to treat cancer and infectious disease. The company was founded by W. Michael Gallatin, Brian K. Farmer, and Robert F. Baltera, Jr. and is headquartered in Kirkland, WA. | Pharmaceuticals: Major | Director/Board Member | |
ALPINE IMMUNE SCIENCES, INC. | Biotechnology | Director/Board Member | |
FHM Life Sciences VIII LLC | Corporate Officer/Principal | ||
Merganser Biotech, Inc.
![]() Merganser Biotech, Inc. BiotechnologyHealth Technology Merganser Biotech, Inc. engages in the development of of hepcidin mimetic peptides as new medicines for the treatment of hematological and iron overload diseases. The company was founded by Brian R. MacDonald and Gene Merutka in 2011 and is headquartered in Newtown Square, PA. | Biotechnology | Director/Board Member | |
ENTASIS THERAPEUTICS HOLDINGS INC. | Biotechnology | Director/Board Member | |
Amunix, Inc.
![]() Amunix, Inc. Pharmaceuticals: MajorHealth Technology Amunix, Inc. develops protein pharmaceuticals. It offers XTEN which is hydrophilic, unstructured, biodegradable polypeptides that impart a number of favorable properties upon the molecules to which they are attached. The company was founded by Volker Schellenberger and Willem Stemmer in 2006 and is headquartered in Mountain View, CA. | Pharmaceuticals: Major | Director/Board Member | |
PHATHOM PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Amunix Pharmaceuticals, Inc.
![]() Amunix Pharmaceuticals, Inc. BiotechnologyHealth Technology Amunix Pharmaceuticals, Inc. manufactures and fabricates drugs. The firm’s pipeline products are based on proprietary XTEN half-life extension, Antibody-XTEN-Drug Conjugate, ProTIA pro-drug and bispecific T-cell engager platform technologies. The company was founded by Willem P.C. Stemmer and Volker Schellenberger in 2006 and is headquartered in Mountain View, CA. | Biotechnology | Director/Board Member | |
Lassen Therapeutics LLC
![]() Lassen Therapeutics LLC Pharmaceuticals: MajorHealth Technology Lassen Therapeutics LLC operates as a therapeutic antibody company. It discovers and develops novel medicines to treat serious unmet medical needs. The company is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member | |
Enlaza Therapeutics, Inc.
![]() Enlaza Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Enlaza Therapeutics, Inc. is a company that develops novel classes of protein therapeutics using their proprietary war-lock™ platform. The company is based in La Jolla, CA. The company's platform utilizes synthetic biology technology for site-specific covalent coupling driven by drug binding. Enlaza Therapeutics is pioneering the field of covalent biologics and aims to deliver more efficacious and safer treatments for patients. The CEO of the company is Sergio G. Duron. | Miscellaneous Commercial Services | Director/Board Member | |
Semnur Pharmaceuticals, Inc.
![]() Semnur Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Semnur Pharmaceuticals, Inc. develops and manufactures pharmaceutical products. The firm focuses on the clinical and commercial development of products such as SP-102: a non-opioid epidural steroid injectable potentially for the treatment of Lumbosacral radicular pain. The company was founded by Mahendra G. Shah in 2013 and is headquartered in Mountain View, CA. | Pharmaceuticals: Major | Director/Board Member | |
ALLENA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
AMICUS THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Azelon Pharmaceuticals, Inc.
![]() Azelon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Azelon Pharmaceuticals, Inc. develops biopharmaceutical drugs for the treatment of osteoporosis. It develops parathyroid hormone analogs for the treatment of bone diseases, which are characterized by deficits in bone formation, including osteoporosis, orthopedic conditions and renal bone disease. The company was founded by Paul Morley and Godfrey Marchand in 2000 and is headquartered in West Conshohocken, PA. | Pharmaceuticals: Major | Director/Board Member | |
Calistoga Pharmaceuticals, Inc.
![]() Calistoga Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Calistoga Pharmaceuticals, Inc. develops and manufactures pharmaceutical products. The company was founded by Michael W. Gallatin, Roger Ulrich and Neil Giese in March 2006 and is headquartered in Tumwater, WA. | Pharmaceuticals: Major | Founder |
Statistics
International
United States | 46 |
United Kingdom | 2 |
Singapore | 2 |
Netherlands | 2 |
Sectoral
Health Technology | 33 |
Finance | 9 |
Consumer Services | 4 |
Commercial Services | 3 |
Distribution Services | 2 |
Operational
Director/Board Member | 156 |
Corporate Officer/Principal | 48 |
Independent Dir/Board Member | 30 |
Chairman | 21 |
Chief Executive Officer | 21 |
Most connected contacts
Insiders | |
---|---|
James Topper | 52 |
Paul Brooke | 32 |
Lonnie Moulder | 31 |
B. Johnson | 26 |
Robert Williamson | 25 |
Robert P. Ryan | 16 |
Alan M. Sebulsky | 14 |
Matthew Likens | 12 |
Eric Hecht | 11 |
Holger Weis | 10 |
Elona Baum | 7 |
Heidi Kempinski | 5 |
Holger Weis | 5 |
Matthew Rebold | 5 |
Lou Ann Beggs | 5 |
- Stock Market
- Insiders
- Shelley A. Hartman
- Company connections